N.41 is an antiviral agent that protects APOBEC3G, an antiviral factor, from HIV Vif protein-mediated degradation; inhibits the Vif-A3G interaction; increases cellular A3G levels and its incorporation into virions; reduces viral infectivity in a Vif-dependent manner; and inhibits HIV-1 replication in PBMCs (IC50: 8.4 μM).